1
|
Chassany O, Engen AV, Lai L, Borhade K, Ravi M, Harnett J, Chen CI, Quek RG. A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncology. Future Oncol 2022; 18:3323-3334. [PMID: 36053168 DOI: 10.2217/fon-2022-0374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Patient-reported outcome (PRO) data are increasingly being included in Health Technology Assessment (HTA) submissions for oncology drugs. This study aims to provide differences in PRO evidence requirements in oncology across key HTA bodies and calls for its harmonization. Method guidance provided by HTA bodies in Germany, France, and the UK, and analysis of HTA reports of 20 oncology case studies were evaluated in this review. Differences exist between HTA bodies regarding guidance on how PRO data should be collected, reported and analyzed as well as how the data are reviewed and considered in oncology HTAs. HTA bodies can play a key role to harmonize PRO method guidance in collaboration with regulators and sponsors.
Collapse
Affiliation(s)
- Olivier Chassany
- Health Economics Clinical Trial Unit, Hôpital Hotel-Dieu, AP-HP, 1 Place du Parvis Notre Dame, Paris, 75004, France.,Patient-Reported Outcomes Unit (PROQOL), UMR 1123, Université Paris Cité, INSERM, Paris, F-75004, France
| | - Anke van Engen
- IQVIA, Herikerbergweg 314, 1101CT Amsterdam, The Netherlands
| | - Livia Lai
- IQVIA, 3 Forbury Place, 23 Forbury Rd, Reading, RG1 3JH, UK
| | - Kunal Borhade
- IQVIA, Omega Block, Embassy Tech Square, Outer Ring Road, Bangalore, 560103, India
| | - Manukiran Ravi
- IQVIA, Omega Block, Embassy Tech Square, Outer Ring Road, Bangalore, 560103, India
| | - James Harnett
- Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA
| | - Chieh-I Chen
- Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA
| | - Ruben Gw Quek
- Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA
| |
Collapse
|